Market Overview:
The global proteomics instrument market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for proteomics instruments for research and clinical applications, technological advancements in proteomics instruments, and growing investments by leading players in the proteomics instrument market. Based on type, the global proteomics instrument market is segmented into mass spectrometry, liquid chromatography, electrophoresis, and others. Mass spectrometry held the largest share of the global proteomics instrument market in 2017 and is expected to maintain its dominance during the forecast period. This can be attributed to its ability to provide high-resolution data that helps identify proteins with great accuracy.andothers).
Product Definition:
Proteomics Instrument is a device that is used to measure the proteins in a sample. It can be used to identify and quantitate proteins in a sample, as well as characterize their post-translational modifications.
Mass Spectrometry:
Mass spectrometry is a technique that is used for the identification and analysis of compounds present in complex mixtures. It has applications in pharmaceutical, biotechnology, food industry, forensic science and chemical research industries. The technology has been evolving over the past few decades owing to technological advancements coupled with increasing demand for high-throughput screening techniques.
Liquid Chromatography:
Liquid chromatography (LC) is a separation method that involves the use of a liquid that can hold solid particles and can move them through it based on their size. The most commonly used liquids are water, ethanol, and chloroform. In this process; the molecules of interest are separated based on their size, polarity & other physical properties such as boiling point or freezing point.
Application Insights:
Oncology accounted for the largest share in 2015 owing to the rising prevalence of cancer and increasing government funding for research in this field. The rise in oncology research is also driven by an increase in number of publications pertaining to proteomics techniques. In addition, presence of key players such as LCPI-Fluoride, Inc., a leader in clinical diagnostics and drug discovery based on mass spectrometry; LCMS-Genomic, a leaderin protein analysis using liquid chromatography & mass spectrometry; and Thermo Fisher Scientifics, Inc.,a global providerof innovative solutions & services related to proteomics & genomics instruments is expected to propel market growth over the forecast period.
The neurology segment is expected grow at a lucrative rate during the study period owingto an increase inthe prevalenceof neurological disordersand growinggovernment fundingfor R&Din thisfield.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of players, increasing R&D investments by various companies and collaborations between academic institutions and pharmaceutical industries. Moreover, rising prevalence of chronic diseases such as cancer, cardiovascular disorders & diabetes is expected to boost the demand for proteomics instruments in North America during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to factors such as improving healthcare infrastructure coupled with an increase in government spending on healthcare research projects & programs pertaining cancer proteomics applications. Furthermore, growing awareness regarding advanced diagnostic technologies among patients will drive regional growth during the forecast period ‰â€˜‘’‘’ “” 2009 Bio-Rad Laboratories., Inc.
Growth Factors:
- Increasing demand for proteomics services and products for biomarker discovery, drug development, and personalized medicine
- Advances in proteomic technologies that improve the speed, accuracy, and cost-effectiveness of protein analysis
- Growing number of research collaborations between academia and industry to develop new applications for proteomics technology
- Increased funding for proteomics research from government agencies and private foundations
- Proliferation of next-generation sequencing platforms that can be used to complement or replace traditional methods in protein analysis
Scope Of The Report
Report Attributes
Report Details
Report Title
Proteomics Instrument Market Research Report
By Type
Mass Spectrometry, Liquid Chromatography, Electrophoresis, Others
By Application
Oncology, Neurology, Cardiovascular, Others
By Companies
AB Sciex (Danaher), Agilent Technologies, Bruker Corporation, Thermo Fisher Scientific, Waters Corporation, Bio-Rad Laboratories, GE Healthcare Life Sciences, JEOL Ltd., Shimadzu Corporation, AB Sciex (Danaher)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
230
Number of Tables & Figures
161
Customization Available
Yes, the report can be customized as per your need.
Global Proteomics Instrument Market Report Segments:
The global Proteomics Instrument market is segmented on the basis of:
Types
Mass Spectrometry, Liquid Chromatography, Electrophoresis, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Oncology, Neurology, Cardiovascular, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AB Sciex (Danaher)
- Agilent Technologies
- Bruker Corporation
- Thermo Fisher Scientific
- Waters Corporation
- Bio-Rad Laboratories
- GE Healthcare Life Sciences
- JEOL Ltd.
- Shimadzu Corporation
- AB Sciex (Danaher)
Highlights of The Proteomics Instrument Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Mass Spectrometry
- Liquid Chromatography
- Electrophoresis
- Others
- By Application:
- Oncology
- Neurology
- Cardiovascular
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Proteomics Instrument Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Proteomics instrument is a laboratory tool used to identify and measure the proteins in a sample.
Some of the key players operating in the proteomics instrument market are AB Sciex (Danaher), Agilent Technologies, Bruker Corporation, Thermo Fisher Scientific, Waters Corporation, Bio-Rad Laboratories, GE Healthcare Life Sciences, JEOL Ltd., Shimadzu Corporation, AB Sciex (Danaher).
The proteomics instrument market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Proteomics Instrument Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Proteomics Instrument Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Proteomics Instrument Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Proteomics Instrument Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Proteomics Instrument Market Size & Forecast, 2020-2028
4.5.1 Proteomics Instrument Market Size and Y-o-Y Growth
4.5.2 Proteomics Instrument Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Mass Spectrometry
5.2.2 Liquid Chromatography
5.2.3 Electrophoresis
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Oncology
6.2.2 Neurology
6.2.3 Cardiovascular
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Proteomics Instrument Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Proteomics Instrument Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Mass Spectrometry
9.6.2 Liquid Chromatography
9.6.3 Electrophoresis
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Oncology
9.10.2 Neurology
9.10.3 Cardiovascular
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Mass Spectrometry
10.6.2 Liquid Chromatography
10.6.3 Electrophoresis
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Oncology
10.10.2 Neurology
10.10.3 Cardiovascular
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Mass Spectrometry
11.6.2 Liquid Chromatography
11.6.3 Electrophoresis
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Oncology
11.10.2 Neurology
11.10.3 Cardiovascular
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Mass Spectrometry
12.6.2 Liquid Chromatography
12.6.3 Electrophoresis
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Oncology
12.10.2 Neurology
12.10.3 Cardiovascular
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Mass Spectrometry
13.6.2 Liquid Chromatography
13.6.3 Electrophoresis
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Oncology
13.10.2 Neurology
13.10.3 Cardiovascular
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Proteomics Instrument Market: Competitive Dashboard
14.2 Global Proteomics Instrument Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 AB Sciex (Danaher)
14.3.2 Agilent Technologies
14.3.3 Bruker Corporation
14.3.4 Thermo Fisher Scientific
14.3.5 Waters Corporation
14.3.6 Bio-Rad Laboratories
14.3.7 GE Healthcare Life Sciences
14.3.8 JEOL Ltd.
14.3.9 Shimadzu Corporation
14.3.10 AB Sciex (Danaher)
